Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC17750
Raltitrexed
雷替曲塞; ZD1694; D1694; ICI-D1694
An inhibitor of thymidylate synthase -
GC12105
Etidronate
羟基乙叉二膦酸,Etidronate; HEDPA; HEDP
A bisphosphonate bone resorption inhibitor -
GC17121
Mycophenolic acid
霉酚酸; Mycophenolate
An immunosuppressive microbial metabolite -
GC13210
Flubendazole
氟苯咪唑
An anthelmintic -
GC11670
Pranoprofen
普拉洛芬
An NSAID and COX-1 inhibitor -
GC11532
Lonidamine
氯尼达明; AF-1890; Diclondazolic Acid; DICA
An inhibitor of hexokinase -
GC12066
Retinyl (Vitamin A) Palmitate
维生素A棕榈酸酯
A natural form of vitamin A -
GC15271
Tyrphostin AG 879
AG 879
A non-specific tyrphostin ErbB2 inhibitor -
GC14273
TTNPB (Arotinoid Acid)
Ro 13-7410; Arotinoid acid; AGN191183
A potent, selective RAR agonist -
GC10469
Sulfamethoxypyridazine
磺胺甲氧哒嗪
A sulfonamide antibiotic -
GC17096
STF-118804
烟酰胺磷酸核糖基转移酶
A Nampt inhibitor -
GC13616
Sodium ascorbate
维生素C钠; Sodium ascorbate; Sodium L-ascorbate; Vitamin C sodium salt
抗坏血酸钠(Sodium L-ascorbate)是一种电子供体,是一种内源性抗氧化剂。抗坏血酸钠选择性抑制 Cav3.2 通道,IC50 为 6.5 μM.抗坏血酸钠也是一种胶原蛋白沉积增强剂和弹性生成抑制剂。 -
GC17393
Pyridoxine HCl
吡哆醇盐酸盐; Pyridoxol hydrochloride; Vitamin B6 hydrochloride
A 4-methanol form of vitamin B6 -
GC11107
PF-573228
6-[(4-((3-(甲磺酰基)苄基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氢-1H-喹啉-2-酮
A selective focal adhesion kinase inhibitor -
GC16007
Methylthiouracil
甲硫氧嘧啶; MTU
甲基硫氧嘧啶是一种抗甲状腺药物。 -
GC13246
Ibandronate sodium
伊班膦酸钠
A bisphosphonate bone resorption inhibitor -
GC15178
Hexamethonium Bromide
六甲溴铵
A nondepolarizing neuromuscular blocking agent -
GC12940
Fidaxomicin
非达霉素; OPT-80; PAR-101
A natural antibiotic -
GC14499
Fenoprofen calcium hydrate
非诺洛芬钙盐二水合物,Fenoprofen calcium salt dihydrate
An NSAID -
GC14622
Diclofenac Potassium
双氯芬酸钾
双氯芬酸钾是一种有效的非选择性抗炎剂,作为 COX 抑制剂,对人 COX-1 和 COX-2 在 CHO 细胞中的 IC50 分别为 4 和 1.3 nM ,对羊 COX- 的 IC50 分别为 5.1 和 0.84 μM。 1 和 COX-2,分别。 -
GC11383
CYT997 (Lexibulin)
CYT-997
An inhibitor of microtubule polymerization -
GC13502
Cysteamine HCl
半胱胺盐酸盐; 2-Aminoethanethiol hydrochloride; 2-Mercaptoethylamine hydrochloride
A radioprotective aminothiol -
GC10813
Clofibric Acid
氯贝酸; Chlorofibrinic acid
A PPARα agonist and the active metabolite of clofibrate -
GC12733
C646
C646是一种有效的选择性p300/CBP组蛋白乙酰转移酶抑制剂(Ki 400 nM),已被证明具有多效性,包括神经保护、抗癌和抗上皮间质转化(anti-EMT)作用。
-
GC14987
GSK-3 Inhibitor IX (BIO)
(2'Z,3'E)-6-溴靛玉红-3'-肟,GSK-3 Inhibitor IX
A potent, selective, and reversible GSK3 inhibitor -
GC14930
Benzbromarone
苯溴马隆
An inhibitor of URAT1 -
GC14314
Aloperine
苦豆碱
An alkaloid with diverse biological activities -
GC11528
Orotic acid
乳清酸; 6-Carboxyuracil; Vitamin B13
乳清酸 (6-Carboxyuracil) 是嘧啶核苷酸和 RNA 生物合成的前体,从线粒体二氢乳清酸脱氢酶 (DHODH) 中释放出来,通过细胞质 UMP 合酶转化为 UMP。 -
GC15760
Ramipril
雷米普利; HOE-498
A prodrug from of ramiprilat -
GC15033
Azathioprine
硫唑嘌呤; BW 57-322
An immunosuppressive purine analog -
GC13339
Ketoprofen
酮洛芬; RP-19583
A non-selective COX inhibitor -
GC16450
Prednisone
强的松; Dehydrocortisone
A synthetic glucocorticoid -
GC13906
Nebivolol hydrochloride
盐酸奈必洛尔; R 065824 hydrochloride
A β1-AR antagonist -
GC12013
Sodium salicylate
水杨酸钠; Salicylic acid sodium salt; 2-Hydroxybenzoic acid sodium salt
水杨酸钠(水杨酸钠盐)抑制环加氧酶 2(COX-2)活性,与转录因子(NF-κB)激活无关。 -
GC11332
Pitavastatin
匹伐他汀; NK-104
Pitavastatin (NK-104) 是一种有效的羟甲基戊二酰辅酶A (HMG-CoA) 还原酶抑制剂。 -
GC12830
Stavudine (d4T)
司他夫定; d4T
An inhibitor of HIV reverse transcriptase -
GC15578
Dienogest
地诺孕素; STS 557
A synthetic progestin and PR agonist -
GC11099
Doxifluridine
去氧氟尿苷; Ro 21-9738; 5-Fluoro-5'-deoxyuridine; 5'-DFUR
An antitumor prodrug of 5-fluorouracil -
GC13835
Toremifene Citrate
枸橼酸托瑞米芬; Z-Toremifene citrate; NK 622; FC-1157a
A selective estrogen receptor modulator -
GC13473
Lenalidomide hemihydrate
来那度胺半水合物; CC-5013 hemihydrate
An analog of thalidomide -
GC14123
GW441756
A potent inhibitor of TrkA
-
GC16077
Deracoxib
地拉考昔; SC 046; SC 46; SC 59046
An NSAID and selective COX-2 inhibitor -
GC16772
Cortisone acetate
醋酸可的松; Cortisone 21-acetate
A synthetic glucocorticoid -
GC12308
Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium
CA 4DP; CA 4P; Combretastatin A4 disodium phosphate
A potent inhibitor of tubulin polymerization -
GC11895
Mevastatin
美伐他汀; Compactin; ML236B
An HMG-CoA reductase inhibitor -
GC13667
Temozolomide
替莫唑胺; NSC 362856; CCRG 81045; TMZ
替莫唑胺是一种口服活性烷化剂,可诱导 DNA 中 O6-甲基鸟嘌呤的形成,其在随后的 DNA 复制周期中与胸腺嘧啶错配,从而激活细胞凋亡途径,替莫唑胺可穿过血脑屏障并适用于恶性神经胶质瘤和转移性黑色素瘤。 -
GC16590
Dimethyl Fumarate
富马酸二甲酯
An antioxidant with immunological actions -
GC15035
PM00104
Potent antimyeloma agent
-
GC14699
CPI-203
A bioavailable inhibitor of BET bromodomains
-
GC15480
Marinopyrrole A
Marinopyrrole A
An alkaloid with antibacterial activity